Publications by authors named "Rory Dodd"

Claim this Profile
D
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.
Wei-Sheng Huang, Shuangying Liu, Dong Zou, Mathew Thomas, Yihan Wang, Rory Dodd

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
Anna Kohlmann, Stephan G Zech, Feng Li, Tianjun Zhou, Rachel M Squillace, Rory Dodd

J Med Chem· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Vijaykumar M Baragi, Gabriel Becher, Alison M Bendele, Ralf Biesinger, Harald Bluhm, Rory Dodd

Arthritis Rheum· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.
Shouming Wang, Hamish Ryder, Ian Pretswell, Paul Depledge, John Milton, Rory Dodd

Bioorg Med Chem Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.
Nigel Vicker, Luke Burgess, Irina S Chuckowree, Rory Dodd, Adrian J Folkes

J Med Chem· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis